Cited by 134Cell Adhesion Molecules ResearchT-cell and B-cell ImmunologyPsoriasis: Treatment and Pathogenesis

Laminin-411 Is a Vascular Ligand for MCAM and Facilitates TH17 Cell Entry into the CNS

Open access
Flanagan, Ken, Fitzgerald, Kent, Baker, Jeanne, Regnstrom, Karin, Gardai, Shyra, Bard, Frederique, Mocci, Simonetta, Seto, Pui +15 more·2012·PLoS ONE

Abstract

TH17 cells enter tissues to facilitate pathogenic autoimmune responses, including multiple sclerosis (MS). However, the adhesion molecules involved in the unique migratory capacity of TH17 cells, into both inflamed and uninflamed tissues remain unclear. Herein, we characterize MCAM (CD146) as an adhesion molecule that defines human TH17 cells in the circulation; following in vitro restimulation of human memory T cells, nearly all of the capacity to secrete IL-17 is contained within the population of cells expressing MCAM. Furthermore, we identify the MCAM ligand as laminin 411, an isoform of laminin expressed within the vascular endothelial basement membranes under inflammatory as well as homeotstatic conditions. Purified MCAM-Fc binds to laminin 411 with an affinity of 27 nM, and recognizes vascular basement membranes in mouse and human tissue. MCAM-Fc binding was undetectable in tissue from mice with targeted deletion of laminin 411, indicating that laminin 411 is a major tissue ligand for MCAM. An anti-MCAM monoclonal antibody, selected for inhibition of laminin binding, as well as soluble MCAM-Fc, inhibited T cell adhesion to laminin 411 in vitro. When administered in vivo, the antibody reduced TH17 cell infiltration into the CNS and ameliorated disease in an animal model of MS. Our data suggest that MCAM and laminin 411 interact to facilitate TH17 cell entry into tissues and promote inflammation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0040443

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • MCAM+ effector T cells migrate more efficiently across the BBB than MCAM-negative counterparts through homotypic binding with MCAM on vascular endothelial cells and interactions with laminin-411.

    “MCAM+ effector T cells migrate more efficiently across the BBB than their MCAM-negative counterparts and appear to do so through homotypic binding with MCAM expressed on vascular endothelial cells (123) and through interactions with laminin-411 (124).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [25]Dagur PK Biancotto A Wei L Nida Sen H Yao M 2011 MCAM-expressing CD4(+) T cells in peripheral blood secrete IL-17A and are significantly elevated in inflammatory autoimmune diseases. J Autoimmun 37(4) 319 327 21959269 PMC3223259

Cited by

Sorted by citations

Authors
Flanagan, K., Fitzgerald, K., Baker, J., Regnstrom, K., Gardai, S., Bard, F., Mocci, S., Seto, P., You, M., Larochelle, C., Prat, A., Chow, S., Li, L., Vandevert, C., Zago, W., Lorenzana, C., Nishioka, C., Hoffman, J., Botelho, R., Willits, C., Tanaka, K., Johnston, J., & Yednock, T.
Affiliations
  • Elan Pharmaceuticals, Inc. (Ireland) (IE)
  • Université de Montréal (CA)
Corresponding author
Flanagan, Ken
Venue
PLoS ONE
Published
2012-07-06
Volume
7
Issue
7
Pages
e40443
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1981126128
Cited by
134
References
53
Citations by year
2026: 8 · 2025: 4 · 2024: 5 · 2023: 6 · 2022: 11 · 2021: 9 · 2020: 8 · 2019: 11 · 2018: 9 · 2017: 14 · 2016: 5 · 2015: 17 · 2014: 13 · 2013: 11 · 2012: 3
FWCI
10.40
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
Karolinska Institutet
Topics
  • Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords
laminin-411, CD146, Th17 cells, T cell adhesion, T cell migration, multiple sclerosis, vascular basement membrane, IL-17, autoimmune inflammation
MeSH terms
Interleukin-22, Animals, Cell Movement, Choroid Plexus, Encephalomyelitis, Autoimmune, Experimental, Extracellular Matrix, Female, Cricetinae, Humans, Interleukins, Laminin, Ligands, Protein Binding, CHO Cells, Cell Polarity, Mice, Knockout, Interleukin-17, Cell Proliferation, Mice, CD146 Antigen, Interleukin-1beta, Th17 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review